Abstract
Some basic metabolites of butyrophenone‐type agents are more neurotoxic than the parent compounds. We have developed a high performance liquid chromatography method with dual ultraviolet detection (HPLC‐dual UV method) to quantify simultaneously the four basic metabolites {1,3‐dihydro‐1‐(1,2,3,6‐tetrahydro‐4‐pyridinyl)‐2H‐benzimidazole‐2‐one, (DTP) 1‐phenyl‐1,3,8‐triazaspiro[4.5] decan‐4‐one (PTS), 4‐(4‐chlorophenyl)‐4‐hydroxypiperidine (CPHP), and 4‐(4‐bromophenyl)‐4‐hydroxypiperidine (BPHP)} of droperidol, spiperone, haloperidol, and bromperidol, respectively. DTP, PTS, CPHP, and BPHP were monitored at their UV maxima (278, 247, 220, and 220 nm, respectively) and also at 200 nm. A reversed‐phase (C18) column was eluted with a mixture of acetonitrile‐water‐85% phosphoric acid (80:920:1, v/v/v) at a flow rate of 1.0 mL/min at 25°C. The four basic metabolites were well separated from each other in less than 25 min. The lower limits of detection were 8 to 20 ng/mL with detection at the UV absorption maxima, and 5 to 12 ng/mL with detection at 200 nm. The coefficients of variation for intra‐and inter‐day assays were less than 13.4%. The recoveries were satisfactory. These results confirm that the HPLC‐dual UV method is satisfactory for the simultaneous assay of DTP, PTS, CPHP, and BPHP in phosphate‐buffered saline.